Application note
The antibodies against phospho-AKT(Ser473) (4060), AKT(pan) (4691), phospho-p70S6K(Thr389) (9205), p70S6K (2708), phospho-ERK1/2(Thr202/Tyr204) (4370), ERK1/2 (4695), phospho-S6 ribosomal protein (Ser235/236) (4858), S6 ribosomal protein (2217), phospho-MDM2(Ser166) (3521), phospho-MEK1/2(Ser217/221) (9154), MEK1/2 (8727), MEK1 (12671), and cleaved caspase 3 (9664) were purchased from Cell Signaling (1:1000 or 1:2000 dilution)
Love, passion, beauty and desire: these are the key concepts of the new men's fragrance by versace
A simple way to start is through a brightening face wash that delivers the active as part of your daily cleansing step
Multi-Pathway Synergy Research KLOW is unique because it allows researchers to study: peptide synergy effects combined regenerative signalling cross-pathway biological interactions Storage & Handling For optimal stability: Store at 28C Keep vial sealed when not in use Avoid moisture exposure After reconstitution, refrigerate immediately Use within validated laboratory timeframes Important Notice (Legal & Compliance) KLOW 80mg is supplied strictly for: Laboratory research In-vitro testing Scientific analysis Educational study purposes Not for human consumption Not for therapeutic or medical use Not for injection or self-administration All buyers must be qualified to handle research chemicals in accordance with Australian regulations.
.webp)
.webp)
